Ann B Eldrup

Title: Ann B Eldrup: Innovator in Gene Modulation

Introduction

Ann B Eldrup is a prominent inventor based in Newtown, CT (US). She has made significant contributions to the field of gene modulation through her innovative research and development. Her work focuses on the creation of compositions that can effectively target nucleic acid molecules, thereby modulating gene expression.

Latest Patents

Ann B Eldrup holds 1 patent for her invention titled "Compositions comprising alternating 2'-modified nucleosides for use in gene modulation." This invention provides compositions that include at least one oligomeric compound with an alternating motif, which is designed to be complementary to a nucleic acid target. The compositions are particularly useful for targeting selected nucleic acid molecules and modulating the expression of one or more genes. In preferred embodiments, these compositions hybridize to a portion of a target RNA, resulting in the loss of normal function of the target RNA. Additionally, the invention outlines methods for modulating gene expression.

Career Highlights

Ann B Eldrup is currently associated with Ionis Pharmaceuticals, Inc., where she continues to advance her research in gene modulation. Her work has been instrumental in developing innovative solutions that have the potential to impact therapeutic approaches in genetic medicine.

Collaborations

Throughout her career, Ann has collaborated with notable colleagues, including Charles Allerson and Balkrishen Bhat. These collaborations have further enriched her research and contributed to the advancement of her inventions.

Conclusion

Ann B Eldrup is a trailblazer in the field of gene modulation, with her innovative patent showcasing her expertise and dedication to advancing genetic research. Her contributions are paving the way for future developments in this critical area of science.